Your Questions Answered Led by trained medical professionals delivering safe, effective, and scientifically backed aesthetic and wellness treatments
Bmj (1997) 315(7103):27981
These medications, particularly Glucagon-Like Peptide-1 (GLP-1) receptor agonists such as semaglutide and tirzepatide, have been clinically validated to treat both conditions, triggering metabolic cascades that significantly improve disease outcomes
This improves AI accuracy and trust , compresses cycle times for eCTD/CMC/BMR , and cuts rework and rejection risk, crucial as GLP-1 demand grew ~ 38% annually (20222024) and compounding workarounds wound down in 2025
Metformin has been associated with reduced vitamin B12 absorption through effects on calcium-dependent membrane action in the terminal ileum, which may be relevant for patients on chronic metformin therapy
E N D Presentation Transcript INCRETINS Glucagon-like Peptide 1 (GLP-1)and Glucose-Dependent Insulinotrophic Polypeptide (GIP) account for ~90% of the incretin effect In response to equivalent hyperglycemic stimuli, ORAL glucose elicits a greater insulin response than IV glucose Insulin Glucose-Stimulated Secretion of Insulin Glucose GLUT2 Pancreatic Cell SUR Glucose Potassium channel GK K+ Pyruvate GLP-1 ATP + ATP GIP TCA Cycle* AC + Calcium channel cAMP [Ca2+] Amplifying Triggering AC = adenylyl cyclase